Back to Search Start Over

Anti-inflammatory constituents from the root of Litsea cubeba in LPS-induced RAW 264.7 macrophages.

Authors :
Lin, Bing
Sun, Lian-Na
Xin, Hai-Liang
Nian, Hua
Song, Hong-Tao
Jiang, Yi-Ping
Wei, Zhen-Qiao
Qin, Lu-Ping
Han, Ting
Source :
Pharmaceutical Biology; Sep2016, Vol. 54 Issue 9, p1741-1747, 7p
Publication Year :
2016

Abstract

ContextLitsea cubeba(Lour.) Pers. (Lauraceae) has long been used as a folk remedy in Traditional Chinese Medicine (TCM) for the treatment of rheumatic diseases. Previous studies from our laboratory indicated thatL. cubebaextract showed anti-arthritic activity in rats. ObjectiveTo studyL. cubebachemically and biologically and to find the potential constituents responsible for its anti-arthritic effect. Materials and methodsThe compounds were isolated from the root ofL. cubebaby column chromatography which eluted with PE:EtOAc gradient system, and the structures were elucidated by detailed spectroscopic data analysis; the anti-inflammatory activity of the isolated compounds was evaluated by lipopolysaccharide (LPS)-induced RAW 264.7 cells and the TNF-α and NO level were measured by ELISA (commercial kit); The iNOS and COX-2 mRNA expression were measured by RT-PCR and the phosphorylation of IκBα, IKKβ, P38 and Akt were determined by western blots. ResultsA novel 9-fluorenone, 1-ethoxy-3,7-dihydroxy-4,6-dimethoxy-9-fluorenone (1), together with 4 known compounds, namely pinoresinol (2), syringaresinol (3), 9,9′-O-di-(E)-feruloyl-meso-5,5′-dimethoxysecoisolariciresinol (4) and lyoniresinol (5) were isolated from the root ofL. cubebafor the first time. The IC50for NO inhibition on compounds1and4were 56.1 ± 1.2 and 32.8 ± 2.3 μM, respectively. The IC50for TNF-α inhibition were 28.2 ± 0.9 and 15.0 ± 1.0 μM, respectively. Both1and4suppress mRNA expression of iNOS, COX-2 and protein phosphorylation of IκBα, IKKβ in LPS-induced RAW 264.7 cells. Discussion and conclusionCompounds1and4isolated fromL. cubebaexhibited potent anti-inflammatory activity through the NF-κB signal pathway. [ABSTRACT FROM PUBLISHER]

Details

Language :
English
ISSN :
13880209
Volume :
54
Issue :
9
Database :
Complementary Index
Journal :
Pharmaceutical Biology
Publication Type :
Academic Journal
Accession number :
117672010
Full Text :
https://doi.org/10.3109/13880209.2015.1126619